Trials / Completed
CompletedNCT02447120
Topcon 3D OCT-1 Maestro Reference Database Study II
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 504 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.
Detailed description
The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D OCT-1 Maestro | OCT machines used for diagnostic purposes |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2015-05-18
- Last updated
- 2022-06-08
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02447120. Inclusion in this directory is not an endorsement.